The positron emission tomography/computed tomography (PET/CT) has been a new tool utilized in the diagnosis and staging of various cancers. However, common worldwide utilization of the PET/CT includes some economic, legal, and ethic controversies. Although PET/CT scanning can detect colorectal premalignant lesions in an early treatable stage, most governments' health care system does not pay for it as a screening test because of its economic burden. Thus, people are forced to make vital decisions about their health because of health policies of their governments. Here, we present an unusual case and discuss the utilization of PET/CT for detection of incidental neoplasms.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127980PMC
http://dx.doi.org/10.1007/s12262-016-1477-yDOI Listing

Publication Analysis

Top Keywords

positron emission
8
emission tomography/computed
8
tomography/computed tomography
8
utilization pet/ct
8
unexpected benefit
4
benefit positron
4
tomography f-fluorodeoxyglucose
4
f-fluorodeoxyglucose report
4
report case
4
case positron
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!